How is chronic laryngitis treated?

Chronic laryngitis can be managed through various approaches, including modification of daily voice-use habits, physical therapy targeting the larynx, local laryngeal medication, systemic oral medications, and surgical intervention. Given its prolonged course, chronic laryngitis may be triggered by excessive voice use, tobacco or alcohol exposure, or recurrent upper respiratory tract infections. Treatment should be individualized based on the patient’s specific circumstances. Prompt medical evaluation and treatment are essential if persistent or worsening hoarseness, dyspnea, or a sensation of airway constriction occurs.

1. Adjustment of Daily Voice-Use Habits: This constitutes a foundational intervention. It involves limiting speaking duration, avoiding shouting or loud vocalizations, and refraining from prolonged voice use. Smoking and alcohol consumption should be discontinued, and exposure to irritants such as dust and cooking fumes minimized. Frequent intake of warm water helps maintain mucosal moisture in the larynx. Reducing persistent mucosal irritation alleviates vocal cord congestion and edema, thereby creating favorable conditions for laryngeal tissue repair.

2. Physical Therapy for the Larynx: Common modalities include nebulized inhalation and laryngeal steam inhalation, both aimed at moisturizing the vocal cords and laryngeal mucosa to reduce localized congestion and edema. These therapies also help thin viscous secretions within the larynx and relieve symptoms such as dryness, pain, and foreign-body sensation. Regular, periodic therapy improves local laryngeal blood circulation and alleviates discomfort associated with chronic inflammation—making it suitable for most patients with chronic laryngitis.

3. Local Laryngeal Medication: Topical laryngeal medications act directly on affected areas within the larynx, reducing mucosal inflammatory responses and alleviating vocal cord congestion to improve hoarseness. Because drug action is highly localized, systemic side effects are minimized. Administration must follow professional guidance, with careful attention to treatment duration and close monitoring of changes in voice quality and laryngeal sensation.

4. Systemic Oral Medications: When local interventions alone yield limited improvement—and especially when systemic symptoms accompany pharyngolaryngeal discomfort—oral medications may be prescribed to modulate overall physiological status and mitigate chronic laryngeal inflammation. Used synergistically with local treatments, these agents help regulate mucosal metabolism and alleviate recurrent hoarseness and throat dryness or pruritus. During treatment, patients should monitor their general condition, adhere to a light diet, and document fluctuations in symptom severity.

5. Surgical Intervention: Surgery may be considered when vocal cord hypertrophy or hyperplasia persists despite conservative management and fails to respond adequately. Procedures aim to remove hyperplastic tissue and restore optimal vocal cord closure, thereby resolving refractory hoarseness. Prior to surgery, comprehensive laryngoscopic evaluation is mandatory to confirm surgical indications. Postoperatively, adequate rest and scheduled follow-up examinations are critical to minimize disease recurrence.

In daily life, protective measures for the respiratory tract should be prioritized: limit speech during colds or upper respiratory infections, maintain appropriate indoor humidity, follow a balanced diet, and safeguard vocal cord health—all of which collectively reduce the risk of recurrent chronic laryngitis.